Abstract: The present invention relates to a dietary supplement or pharmaceutical composition, comprising lyophylized Saccharomyces boulardii as an active ingredient and as sole probiotic, optionally in association with a pharmaceutically acceptable vehicle, wherein the composition is in a closed vial a having a first airtight compartment comprising lyophilized S. boulardii powder, and a second compartment comprising a solution, wherein the first and second compartment can be brought in airtight communication with one another to yield a suspension of S. boulardii to be administered to an individual upon opening of the vial.

Abstract: The present invention relates to a dietary supplement or pharmaceutical composition, comprising lyophylized Saccharomyces boulardii as an active ingredient and as sole probiotic, optionally in association with a pharmaceutically acceptable vehicle, wherein the composition is in a closed vial a having a first airtight compartment comprising lyophilized S. boulardii powder, and a second compartment comprising a solution, wherein the first and second compartment can be brought in airtight communication with one another to yield a suspension of S. boulardii to be administered to an individual upon opening of the vial.

Abstract: The invention relates to a composition that may be used in dermatology. The topical antimicrobial dermatological composition for use in human and veterinary medicine comprises in combination at least one cationic antimicrobial peptide and hyaluronic acid of medium molecular weight or a salt thereof. Application to the treatment of cutaneous, integumental or mucosal microbial infections.

Abstract: This invention relates to the use of an active compound selected from the group comprising a sphingoid base, a sphingoid base derivative or a mixture of two or more these compounds for manufacturing a cosmetic composition suitable for topical application with animals having an at least partly fur covered skin for maintaining and/or repairing the keratoseborrheaic condition of the skin and/or fur.

Abstract: The invention relates to an antiseptic composition. The composition comprises an association of at least silver metal, preferably in a micronised form, and hyaluronic acid or one of the salts thereof having a molecular weight of between 50 kDa and 2000 kDa. The invention can be especially applied to the field of veterinary medicine, for the treatment of skin wounds and the healing thereof.

Abstract: This invention relates to the use of an active compound selected from the group comprising a sphingoid base, a sphingoid base derivative or a mixture of two or more these compounds for manufacturing a cosmetic composition suitable for topical application with animals having an at least partly fur covered skin for maintaining and/or repairing the keratoseborrheaic condition of the skin and/or fur.

Abstract: This invention relates to the use of an active compound selected from the group comprising a sphingoid base, a sphingoid base derivative or a mixture of two or more these compounds for manufacturing a cosmetic composition suitable for topical application with animals having an at least partly fur covered skin for maintaining and/or repairing the keratoseborrheaic condition of the skin and/or fur.

Abstract: The invention relates to a composition based on mineral concentrates and a method of preparing this composition. The composition comprises a powder or a mixture of powders containing at least one silicon derivative and at least one trace element other than silicon, as a mixture with a carrier and physiologically acceptable excipients. Application in cosmetology and dermatology for protecting the skin.

Abstract: The invention relates to a novel formulation of use in cosmetology and in dermatology which uses the storage capacity of the sebaceous glands. The formulation is of the spot-on type and comprises a lipophilic active principle chosen from vitamin A, vitamin E a lipophilic agent for combating free radicals, ceramides or sphingoid bases and steroid hormones, in combination with one or more unsaturated C4-C26 fatty acids and a liquid vehicle, having sebaceous tropism. Application to the localized topical administration of lipophilic active principles.

Abstract: The invention relates to a composition based on mineral concentrates. The composition comprises a powder or a mixture of powders containing, on the one hand, at least one silicon derivative and, on the other hand, at least one trace element other than silicon, as a mixture with a carrier and physiologically acceptable excipients. Application in cosmetology and dermatology for protecting the skin.

Abstract: The invention relates to using a composition comprising an association of at least one type of nicotinic acid or nicotinic acid amide and at least one type of sphingoid base in the form of a depigmentation agent. The use of the inventive composition makes it possible simultaneously to promote skin lightening and to control a local skin hyperpigmentation of any nature and origin. Methods for an associated cosmetic treatment and the use of an association of at least one type of nicotinic acid or nicotinic acid amide and at least one type of sphingoid base for preparing a dermatological preparation for controlling hyperpigmentation are also disclosed.

Abstract: This invention relates to the use of an active compound selected from the group comprising a sphingoid base, a sphingoid base derivative or a mixture of two or more these compounds for manufacturing a cosmetic composition suitable for topical application with animals having an at least partly fur covered skin for maintaining and/or repairing the keratoseborrheaic condition of the skin and/or fur.

Abstract: The invention concerns a dermatological composition comprising in combination at least nicotinic acid or a nicotinic acid amide such as nicotinamide (vitamin PP), and at least a sphingoid base selected among sphingosine, sphinganine, phytosph-ingosine, tetracetylphytosphingosine, N-acetylphytosphingosine, and phytosphingosine hydrochloride. The invention is useful for treating atopic dermatitis and acne.

Abstract: Disclosed herein is a dispensing system for benzoyl chloride and an antimicrobial agent which antimicrobial agent is a macrolide or an aminoglycoside antibiotic. The dispensing system comprises a first container containing a composition comprising benzoyl peroxide suspended in an aqueous solvent and further includes a viscosifying agent and a second container containing a second composition, wherein the second composition comprises an antimicrobial agent in a solvent and further comprising a viscosifying agent. The solvent is present in a concentration which is too high for direct application.